Effects of in vivo and in vitro L-arginine supplementation on healthy human vessels

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 1, 1996, Pages 158-166

  Chin Dusting, Jaye P F ^a,b   Alexander, Cathryn T ^a   Arnold, Pamela J ^a   Hodgson, Wayne C ^a,c   Lux, Alan S ^a   Jennings, Garry L R ^a  

^a ALFRED HOSPITAL   (Australia)

^b Monash University ^*  (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Forearm resistance arteries; Humans; L arginine; Nitric oxide; Oral; Subcutaneous arteries

Indexed keywords

ACETYLCHOLINE; N(G) METHYLARGININE; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FOREARM BLOOD FLOW; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN INTAKE; RESISTANCE BLOOD VESSEL; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ADULT; ARGININE; ARTERIES; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FOREARM; HUMANS; LIVER FUNCTION TESTS; MALE; OMEGA-N-METHYLARGININE; PLETHYSMOGRAPHY; VASOCONSTRICTION;

EID: 0029942145     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199607000-00023     Document Type: Article

References (29)

1. Furchgott RF, Zawadzi JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
2. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
3. Dusting GJ. Nitric oxide and vascular disease. Proc Austr Physiol Pharmacol Soc 1993;24:37-53.
4. Palmer RMJ, Rees AA, Ashton DS, Moncada S. L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophy Res Commun 1988;153:1251-6.
5. Gold ME, Bush BA, Ignarro LJ. Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation. Biochem Biophy Res Commun 1989;164:714-21.
6. Mitchell JA, Hecker M, Vane JR. The generation of L-arginine in endothelial cells is linked to the release of endothe- lium-derived relaxing factor. Eur J Pharmacol 1990;176:253-4.
7. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990;87:682-5.
8. Gold ME, Wood, Buga GM, Byrns RE, Ignarro LJ. L-Arginine causes whereas L-arginosuccinic acid inhibits endothelium-dependent vascular smooth muscle relaxation. Biochem Biophy Res Commun 1989;161:536-43.
9. Imaizumi T, Hirooka Y, Masaki H, et al. Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension 1992;20:511-7.
10. Panza JA, Casino PR, Diane MB, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 1993;87;1475-81.
11. Nakaki T, Hihikawa K, Suzuki H, Saruta T, Kalo R. L-Arginine-induced hypotension. Lancet 1990;336:696.
12. Calver A, Collier J, Vallance P. Dilator actions of arginine in human peripheral vasculature. Clin Sci 1991;81:695-700.
13. Barbul A. Arginine: biochemistry, physiology and therapeutic implications. J Parenteral Enteral Nutr 1986;1:227-38.
14. Chin JPF, Gust AP, Nestel PJ, Dart AM. Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans. Hypertension 1993;21:22-8.
15. Chin JPF, Gust AP, Dart AM. Indomethacin inhibits the effects of dietary supplementation with marine oils on vasoconstriction of human forearm resistance vessels in vivo. J Hyperten 1993;11:1229-34.
16. Chin JPF, Kaye DM, Hurlstonn RM, Angus JA, Jennings GL, Dart AM. Effects of dietary marine oil supplementation on reactivity of human buttock subcutaneous arteries and forearm veins in vitro. Br J Pharmacol 1994;112:566-70.
17. Mulvany MJ, Warshaw DM. The active tension-length curve of vascular smooth muscle-related to its cellular components. J Gen Physiol 1979;74:85-104.
18. Matthews JNS, Altman DG, Campbell MJ, Royston P. Anal- ysis of serial measurements in medical research. Br Med J 1990;300:230-5.
19. Nakashima A, Angus JA, Johnston CI. Comparison of angiotensin converting enzyme inhibitors captopril and MK421-diacid in guinea pig atria. Eur J Pharmacol 1982;81:487-92.
20. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolaemic rabbit. J Clin Invest 1992;90:1168-72.
21. Visek WJ. Arginine needs, physiological state and usual diets. A reevaluation. J Nutr 1986;116:36-46.
22. Nakaki T, Kato R. Beneficial circulatory effect of L-arginine. Jpn J Pharmacol 1994;6:167-71.
23. Wu G, Meninger CJ. Regulation of L-arginine synthesis from L-citrulline by L-glutamine in endothelial cells. Am J Physiol 1993;265:H1965-71.
24. Hirooka Y, Imaizumi T, Tagawa T, et al. Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure. Circulation 1994;90:658-68.
25. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilatation in hypercholesterolemic humans. J Clin Invest 1992;90:1248-53.
26. Angus JA, Lew MJ. Interpretation of the acetylcholine test of endothelial cell dysfunction in hypertension. J Hyperten 1992;10:S179-86.
27. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989;86:3375-8.
28. Schmidt HHHW, Baeblich SE, Zernikow BC, Klein MM, Bohme E. L-Arginine and arginine analogues: effects on isolated blood vessels and cultured endothelial cells. Br J Pharmacol 1990;10:145-51.
29. Girerd XJ, Hirsch AT, Cooke JP, Dzau VJ, Creger MA. L-Arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Cir Res 1990;67:1301-8.